Barrett's oesophagus, part 2: Enabling informed patient choice in surveillance

Bailey, Karen
November 2009
Gastrointestinal Nursing;Nov2009, Vol. 7 Issue 9, p30
Academic Journal
Endoscopic surveillance programmes for patients with Barrett's oesophagus aim to detect high-grade dysplasia which may be a precursor to adenocarcinoma. However, Karen Bailey explains that before patients can be enrolled in a surveillance programme, they need to be made aware of the potential harms of surveillance, as well as the realistic chances of cancer developing. Patients need to be given simple, accessible and balanced information in order to make informed choices as to participation in surveillance or screening programmes for any condition. Health professionals also need to have an understanding of patients' perceptions of surveillance and screening programmes and respect the informed decisions made by patients.


Related Articles

  • Endoscopic Therapy of Barrett's Esophagus and Esophageal Adenocarcinoma. Tantau, Marcel; Mosteanu, Ofelia; Pop, Teodora; Tantau, Alina; Mester, Gabriela // Journal of Gastrointestinal & Liver Diseases;Jun2010, Vol. 19 Issue 2, p213 

    The normal squamous esophageal epithelium reacts as a chronic inflammation to the severe gastro-esophageal reflux. Esophagitis will progress to Barrett metaplasia in 10% of patients who would be of minor clinical interest if it then did not advance to low, high grade dysplasia and invasive...

  • Barrett's Esophagus.  // Current Medical Literature: Gastroenterology;2007, Vol. 26 Issue 3, p85 

    The article presents studies related to Barrett's esophagus. These include "Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus," by G. A. Prasad et al, and "Extent of low-grade dysplasia is a risk factor for the development of esophageal...

  • Novel Probe-Based Confocal Laser Endomicroscopy Criteria and Interobserver Agreement for the Detection of Dysplasia in Barrett's Esophagus. Gaddam, Srinivas; Mathur, Sharad C; Singh, Mandeep; Arora, Jaya; Wani, Sachin B; Gupta, Neil; Overhiser, Andrew; Rastogi, Amit; Singh, Vikas; Desai, Neel; Hall, Sandra B; Bansal, Ajay; Sharma, Prateek // American Journal of Gastroenterology;Nov2011, Vol. 106 Issue 11, p1961 

    OBJECTIVES:Probe-based confocal laser endomicroscopy (pCLE) is an imaging technique that allows real-time in vivo histological assessment of Barrett's esophagus (BE). The objectives of this study were to create and test novel pCLE criteria for dysplastic BE (phase I), and to evaluate accuracy,...

  • Management of Nondysplastic Barrett's Esophagus: Where Are We Now? Sharma, Prateek; Falk, Gary W.; Sampliner, Richard; Spechler, Stuart Jon; Wang, Kenneth // American Journal of Gastroenterology;Apr2009, Vol. 104 Issue 4, p805 

    The article discusses the incidence of esophageal adenocarcinoma in Barrett's esophagus (BE) in the U.S. It states that the incidence of esophageal adenocarcinoma has continued to rise at a greater rate compared to any cancer. However, it notes that the majority of BE patients never go on to...

  • Barrett's guidelines update includes screening, surveillance, management.  // Geriatrics;May2008, Vol. 63 Issue 5, p21 

    The article reports on the new guidelines for diagnosing and treating Barrett's esophagus published by the American College for Gastroenterology. According to the guidelines, patients with low-grade dysplasia need follow-up endoscopy within 6 months and those with high-grade dysplasia within...

  • Comparing Treatments for Barrett's Disease.  // Clinician Reviews;Jul2009, Vol. 19 Issue 7, p18 

    The article reports that endoscopic radiofrequency ablation (RFA) was shown to completely eradicate Barrett's esophagus with associated dysplasia. Seventy-seven percent of members of a U.S. registry of patients with Barrett's esophagus who received RFA procedures were found cured of the disease...

  • Barrett's Esophagus and Cancer Risk: How Research Advances Can Impact Clinical Practice. di Pietro, Massimiliano; Alzoubaidi, Durayd; Fitzgerald, Rebecca C. // Gut & Liver;Jul2014, Vol. 8 Issue 4, p356 

    Barrett's esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), whose incidence has increased sharply in the last 4 decades. The annual conversion rate of BE to cancer is significant, but small. The identification of patients at a higher risk of cancer therefore poses a...

  • Barrett's Esophagus: What's the Risk? Kuritzky, Louis // Internal Medicine Alert;12/15/2011, Vol. 33 Issue 23, p183 

    The article offers information on the growing incidence of adenocarcinoma of the esophagus (E-ca) in patients suffering from Barrett's Esophagus with higher degree of dysplasia.

  • Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia. Sharma, Virender K; Jae Kim, H; Das, Ananya; Wells, Christopher D; Nguyen, Cuong C; Fleischer, David E // American Journal of Gastroenterology;Feb2009, Vol. 104 Issue 2, p310 

    OBJECTIVES:Dysplasia in a Barrett's esophagus (BE) is associated with an increased risk for developing esophageal adenocarcinoma. Ablation using the HALO system has shown promise for the treatment of BE with dysplasia. The objective of this study was to assess the safety and efficacy of a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics